VESICA HEALTH Trademark

Trademark Overview

On Sunday, October 22, 2023, a trademark application was filed for VESICA HEALTH with the United States Patent and Trademark Office. The USPTO has given the VESICA HEALTH trademark a serial number of 98234757. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, January 30, 2025. This trademark is owned by Vesica Health, Inc. The VESICA HEALTH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing reagent sample testing and diagnostic services for others for scientific research purposes
vesica health

General Information

Serial Number98234757
Word MarkVESICA HEALTH
Filing DateSunday, October 22, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateThursday, January 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding reagent sample testing and diagnostic services for others for scientific research purposes

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 22, 2023
Primary Code042
First Use Anywhere DateThursday, October 6, 2022
First Use In Commerce DateThursday, October 20, 2022

Trademark Owner History

Party NameVesica Health, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Trademark Events

Event DateEvent Description
Sunday, October 22, 2023NEW APPLICATION ENTERED
Tuesday, January 9, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 23, 2024DIVISIONAL REQUEST RECEIVED
Sunday, June 23, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, June 5, 2024ASSIGNED TO EXAMINER
Thursday, June 6, 2024NON-FINAL ACTION E-MAILED
Thursday, June 6, 2024NON-FINAL ACTION WRITTEN
Monday, August 19, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 30, 2024DIVISIONAL PROCESSING COMPLETE
Saturday, August 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 6, 2024NON-FINAL ACTION WRITTEN
Sunday, January 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, October 6, 2024NON-FINAL ACTION E-MAILED
Sunday, January 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2025FINAL REFUSAL WRITTEN
Thursday, January 30, 2025FINAL REFUSAL E-MAILED
Thursday, January 30, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, January 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

health vesica others scientific research purposes services diagnostic reagent sample testing providing